Understanding how certain immune cells contribute to heart inflammation caused by cancer treatments.
CXCL9/10 Macrophage Induced CXCR3+ T-cell Recruitment to the Heart Contributes to Immunotherapy Myocarditis
This study is looking at how certain immune cells can cause heart inflammation in people receiving cancer treatment, with the goal of finding ways to keep patients safer during their therapy.
Quick facts
| Grant type | R03 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stanford University NIH-funded |
| Lab location | 1 site (Stanford, United States) |
| Project ID | NIH-10867164 on NIH RePORTER |
What this research studies
This research investigates the role of specific immune cells, particularly macrophages and T-cells, in causing heart inflammation known as myocarditis, which can occur as a side effect of cancer immunotherapy. By using advanced mouse models and high-throughput techniques, the study aims to understand how these immune cells interact and contribute to heart damage. The findings could lead to better management strategies for patients experiencing this serious side effect, ultimately improving their safety during cancer treatment.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients undergoing immunotherapy for advanced cancer who may be at risk for myocarditis.
Not a fit: Patients not receiving immunotherapy or those without a history of heart issues may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments that minimize heart inflammation in patients receiving immunotherapy for cancer.
How similar studies have performed: Previous research has shown that understanding immune cell interactions can lead to significant advancements in managing side effects of cancer treatments, indicating potential for success in this area.
Where this research is happening
Stanford, United States
- Stanford University — Stanford, United States (Active)
Researchers
- Principal investigator: Zhu, Han — Stanford University
- Study coordinator: Zhu, Han
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.